
Bernard I. Dentz
Examiner (ID: 10168)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 2899, 1622, 1201, 1203, 1612, 5333, 1625 |
| Total Applications | 3129 |
| Issued Applications | 2568 |
| Pending Applications | 93 |
| Abandoned Applications | 468 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11521580
[patent_doc_number] => 09604966
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Crizotinib preparation method'
[patent_app_type] => utility
[patent_app_number] => 14/647450
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3571
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647450
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/647450 | Crizotinib preparation method | Feb 12, 2014 | Issued |
Array
(
[id] => 9657346
[patent_doc_number] => 20140228350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'TRICYCLIC COMPOUND DERIVATIVES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY DISORDERS AND IMMUNOMODULATORY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/156314
[patent_app_country] => US
[patent_app_date] => 2014-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 72388
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14156314
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/156314 | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | Jan 14, 2014 | Issued |
Array
(
[id] => 9569871
[patent_doc_number] => 20140187584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and -1-Oxoisoindolines and Method of Reducing TNFalpha Levels'
[patent_app_type] => utility
[patent_app_number] => 14/156325
[patent_app_country] => US
[patent_app_date] => 2014-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15708
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14156325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/156325 | Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and -1-Oxoisoindolines and Method of Reducing TNFalpha Levels | Jan 14, 2014 | Abandoned |
Array
(
[id] => 9462895
[patent_doc_number] => 20140127322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'SOLID FORMS OF AN AZOCYCLIC AMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/153155
[patent_app_country] => US
[patent_app_date] => 2014-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38029
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14153155
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/153155 | Solid forms of an azocyclic amide | Jan 12, 2014 | Issued |
Array
(
[id] => 9721067
[patent_doc_number] => 20140256769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'CRYSTALLINE FORM OF A QUINOLINONE-CARBOXAMIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/150059
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15277
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14150059
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/150059 | Crystalline form of a quinolinone-carboxamide compound | Jan 7, 2014 | Issued |
Array
(
[id] => 9450040
[patent_doc_number] => 20140121210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'ASYMMETRIC UREAS AND MEDICAL USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/150360
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21178
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14150360
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/150360 | Asymmetric ureas and medical uses thereof | Jan 7, 2014 | Issued |
Array
(
[id] => 10468524
[patent_doc_number] => 20150353541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'Novel intermediate and polymorphs of 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetra hydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and process thereof'
[patent_app_type] => utility
[patent_app_number] => 14/759712
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9070
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759712
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759712 | Intermediate and polymorphs of 1-(4-methoxypheny1)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetra hydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and process thereof | Jan 7, 2014 | Issued |
Array
(
[id] => 9562024
[patent_doc_number] => 20140179737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'PIPERIDINE-2, 6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/133335
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10762
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14133335
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/133335 | Piperidine-2, 6-dione derivatives and their use as tumor necrosis factor inhibitors | Dec 17, 2013 | Issued |
Array
(
[id] => 9562210
[patent_doc_number] => 20140179924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Process for the preparation of cathepsin S inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/102413
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 45503
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14102413
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/102413 | Process for the preparation of cathepsin S inhibitors | Dec 9, 2013 | Abandoned |
Array
(
[id] => 10430160
[patent_doc_number] => 20150315172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'PYRIDONE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/650152
[patent_app_country] => US
[patent_app_date] => 2013-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36534
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650152
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/650152 | Pyridone compound | Dec 5, 2013 | Issued |
Array
(
[id] => 9686604
[patent_doc_number] => 20140243369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'SYNTHESIS OF A GLYCOSYLTRANSFERASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/097398
[patent_app_country] => US
[patent_app_date] => 2013-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3062
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14097398
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/097398 | Synthesis of a glycosyltransferase inhibitor | Dec 4, 2013 | Issued |
Array
(
[id] => 9989855
[patent_doc_number] => 09035061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Process for preparing a biphenyl-2-ylcarbamic acid'
[patent_app_type] => utility
[patent_app_number] => 14/090211
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7668
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090211
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/090211 | Process for preparing a biphenyl-2-ylcarbamic acid | Nov 25, 2013 | Issued |
Array
(
[id] => 10414113
[patent_doc_number] => 20150299123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'S1P AND/OR ATX MODULATING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/443944
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45464
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443944
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443944 | S1P and/or ATX modulating agents | Nov 19, 2013 | Issued |
Array
(
[id] => 10414160
[patent_doc_number] => 20150299170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'FLUORO-DERIVATIVES OF PYRAZOLE-SUBSTITUTED AMINO-HETEROARYL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/646695
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17453
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646695
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646695 | FLUORO-DERIVATIVES OF PYRAZOLE-SUBSTITUTED AMINO-HETEROARYL COMPOUNDS | Nov 19, 2013 | Abandoned |
Array
(
[id] => 9363796
[patent_doc_number] => 20140073669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => '4\'-O-SUBSTITUTED ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/083205
[patent_app_country] => US
[patent_app_date] => 2013-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31098
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14083205
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/083205 | 4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same | Nov 17, 2013 | Issued |
Array
(
[id] => 9363799
[patent_doc_number] => 20140073672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'NOVEL PYRAZOLONE-DERIVATIVES AND THEIR USE AS PDE-4 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/080881
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52379
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14080881
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/080881 | Pyrazolone-derivatives and their use as PDE-4 inhibitors | Nov 14, 2013 | Issued |
Array
(
[id] => 10129159
[patent_doc_number] => 09162982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-20
[patent_title] => '4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds'
[patent_app_type] => utility
[patent_app_number] => 14/070887
[patent_app_country] => US
[patent_app_date] => 2013-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14070887
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/070887 | 4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds | Nov 3, 2013 | Issued |
Array
(
[id] => 9331153
[patent_doc_number] => 20140057935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'NOVEL FORMS OF TIOTROPIUM BROMIDE AND PROCESSES FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/068998
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12255
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/068998 | NOVEL FORMS OF TIOTROPIUM BROMIDE AND PROCESSES FOR PREPARATION THEREOF | Oct 30, 2013 | Abandoned |
Array
(
[id] => 10032552
[patent_doc_number] => 09073859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound'
[patent_app_type] => utility
[patent_app_number] => 14/060846
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 15604
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14060846
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/060846 | Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound | Oct 22, 2013 | Issued |
Array
(
[id] => 11805140
[patent_doc_number] => 09546152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-17
[patent_title] => '2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 14/437713
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25098
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437713
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437713 | 2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists | Oct 20, 2013 | Issued |